APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anticholinergic Agent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anticholinergic Agent Industry Growth and Trends Forecast to 2032

29 December 2025117 pages

Choose your research edition.

Industry ResearchAnticholinergic Agent Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Anticholinergic Agent Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Anticholinergic Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anticholinergic Agent Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Anticholinergic Agent Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Anticholinergic Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anticholinergic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anticholinergic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anticholinergic Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anticholinergic Agent include Astellas Pharma Inc, Aurobindo Pharma, Boehringer Ingelheim, GlaxoSmithKline, Macleods Pharmaceuticals, Novartis AG, Perrigo, Teva Pharmaceutical and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anticholinergic Agent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anticholinergic Agent market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anticholinergic Agent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anticholinergic Agent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anticholinergic Agent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anticholinergic Agent Market by Company

Astellas Pharma Inc

Aurobindo Pharma

Boehringer Ingelheim

GlaxoSmithKline

Macleods Pharmaceuticals

Novartis AG

Perrigo

Teva Pharmaceutical

AstraZeneca

AbbVie

Hansoh Pharmaceutical

Hengrui

Pfizer

Joincare Pharmaceutical

Mylan

Sanofi

Sun Pharmaceutical

Anticholinergic Agent Segment by Type

Muscarinic Antagonists

Nicotinic Antagonists

Anticholinergic Agent Segment by Application

Chronic Obstructive Pulmonary Disease

Parkinson's Disease

Surgery

Asthma

Anticholinergic Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anticholinergic Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anticholinergic Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anticholinergic Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anticholinergic Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anticholinergic Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Muscarinic Antagonists Table 2. Major Company of Nicotinic Antagonists Table 3. Global Anticholinergic Agent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Anticholinergic Agent Sales by Type (2021-2026) & (Kg) Table 5. Global Anticholinergic Agent Sales Market Share in Volume by Type (2021-2026) Table 6. Global Anticholinergic Agent Sales by Type (2021-2026) & (US$ Million) Table 7. Global Anticholinergic Agent Sales Market Share in Value by Type (2021-2026) Table 8. Global Anticholinergic Agent Price by Type (2021-2026) & (US$/g) Table 9. Global Anticholinergic Agent Sales by Type (2027-2032) & (Kg) Table 10. Global Anticholinergic Agent Sales Market Share in Volume by Type (2027-2032) Table 11. Global Anticholinergic Agent Sales by Type (2027-2032) & (US$ Million) Table 12. Global Anticholinergic Agent Sales Market Share in Value by Type (2027-2032) Table 13. Global Anticholinergic Agent Price by Type (2027-2032) & (US$/g) Table 14. North America Anticholinergic Agent Sales by Type (2021-2026) & (Kg) Table 15. North America Anticholinergic Agent Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Anticholinergic Agent Sales by Type (2021-2026) & (Kg) Table 17. Europe Anticholinergic Agent Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Anticholinergic Agent Sales by Type (2021-2026) & (Kg) Table 19. Asia-Pacific Anticholinergic Agent Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Anticholinergic Agent Sales by Type (2021-2026) & (Kg) Table 21. Latin America Anticholinergic Agent Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Anticholinergic Agent Sales by Type (2021-2026) & (Kg) Table 23. Middle East and Africa Anticholinergic Agent Sales by Type (2021-2026) & (US$ Million) Table 24. Anticholinergic Agent Industry Trends Table 25. Anticholinergic Agent Industry Drivers Table 26. Anticholinergic Agent Industry Opportunities and Challenges Table 27. Anticholinergic Agent Industry Restraints Table 28. Global Anticholinergic Agent Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Anticholinergic Agent Revenue Market Share by Company (2021-2026) Table 30. Global Anticholinergic Agent Sales by Company (2021-2026) & (Kg) Table 31. Global Anticholinergic Agent Sales Share by Company (2021-2026) Table 32. Global Anticholinergic Agent Market Price by Company (2021-2026) & (US$/g) Table 33. Global Anticholinergic Agent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Anticholinergic Agent Major Company Production Sites and Headquarters Table 35. Global Anticholinergic Agent Company, Product Type & Application Table 36. Global Anticholinergic Agent Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Anticholinergic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Anticholinergic Agent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Anticholinergic Agent Sales by Region (2021-2026) & (Kg) Table 41. Global Anticholinergic Agent Sales Market Share in Volume by Region (2021-2026) Table 42. Global Anticholinergic Agent Sales by Region (2021-2026) & (US$ Million) Table 43. Global Anticholinergic Agent Sales Market Share in Value by Region (2021-2026) Table 44. Global Anticholinergic Agent Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 45. Global Anticholinergic Agent Sales by Region (2027-2032) & (Kg) Table 46. Global Anticholinergic Agent Sales Market Share in Volume by Region (2027-2032) Table 47. Global Anticholinergic Agent Sales by Region (2027-2032) & (US$ Million) Table 48. Global Anticholinergic Agent Sales Market Share in Value by Region (2027-2032) Table 49. Global Anticholinergic Agent Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 50. Global Anticholinergic Agent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Anticholinergic Agent Sales by Application (2021-2026) & (Kg) Table 52. Global Anticholinergic Agent Sales Market Share in Volume by Application (2021-2026) Table 53. Global Anticholinergic Agent Sales by Application (2021-2026) & (US$ Million) Table 54. Global Anticholinergic Agent Sales Market Share in Value by Application (2021-2026) Table 55. Global Anticholinergic Agent Price by Application (2021-2026) & (US$/g) Table 56. Global Anticholinergic Agent Sales by Application (2027-2032) & (Kg) Table 57. Global Anticholinergic Agent Sales Market Share in Volume by Application (2027-2032) Table 58. Global Anticholinergic Agent Sales by Application (2027-2032) & (US$ Million) Table 59. Global Anticholinergic Agent Sales Market Share in Value by Application (2027-2032) Table 60. Global Anticholinergic Agent Price by Application (2027-2032) & (US$/g) Table 61. North America Anticholinergic Agent Sales by Application (2021-2026) & (Kg) Table 62. North America Anticholinergic Agent Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Anticholinergic Agent Sales by Application (2021-2026) & (Kg) Table 64. Europe Anticholinergic Agent Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Anticholinergic Agent Sales by Application (2021-2026) & (Kg) Table 66. Asia-Pacific Anticholinergic Agent Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Anticholinergic Agent Sales by Application (2021-2026) & (Kg) Table 68. Latin America Anticholinergic Agent Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Anticholinergic Agent Sales by Application (2021-2026) & (Kg) Table 70. Middle East and Africa Anticholinergic Agent Sales by Application (2021-2026) & (US$ Million) Table 71. Astellas Pharma Inc Company Information Table 72. Astellas Pharma Inc Business Overview Table 73. Astellas Pharma Inc Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 74. Astellas Pharma Inc Anticholinergic Agent Product Portfolio Table 75. Astellas Pharma Inc Recent Development Table 76. Aurobindo Pharma Company Information Table 77. Aurobindo Pharma Business Overview Table 78. Aurobindo Pharma Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 79. Aurobindo Pharma Anticholinergic Agent Product Portfolio Table 80. Aurobindo Pharma Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Anticholinergic Agent Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Anticholinergic Agent Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Macleods Pharmaceuticals Company Information Table 92. Macleods Pharmaceuticals Business Overview Table 93. Macleods Pharmaceuticals Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 94. Macleods Pharmaceuticals Anticholinergic Agent Product Portfolio Table 95. Macleods Pharmaceuticals Recent Development Table 96. Novartis AG Company Information Table 97. Novartis AG Business Overview Table 98. Novartis AG Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 99. Novartis AG Anticholinergic Agent Product Portfolio Table 100. Novartis AG Recent Development Table 101. Perrigo Company Information Table 102. Perrigo Business Overview Table 103. Perrigo Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 104. Perrigo Anticholinergic Agent Product Portfolio Table 105. Perrigo Recent Development Table 106. Teva Pharmaceutical Company Information Table 107. Teva Pharmaceutical Business Overview Table 108. Teva Pharmaceutical Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 109. Teva Pharmaceutical Anticholinergic Agent Product Portfolio Table 110. Teva Pharmaceutical Recent Development Table 111. AstraZeneca Company Information Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 114. AstraZeneca Anticholinergic Agent Product Portfolio Table 115. AstraZeneca Recent Development Table 116. AbbVie Company Information Table 117. AbbVie Business Overview Table 118. AbbVie Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 119. AbbVie Anticholinergic Agent Product Portfolio Table 120. AbbVie Recent Development Table 121. Hansoh Pharmaceutical Company Information Table 122. Hansoh Pharmaceutical Business Overview Table 123. Hansoh Pharmaceutical Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 124. Hansoh Pharmaceutical Anticholinergic Agent Product Portfolio Table 125. Hansoh Pharmaceutical Recent Development Table 126. Hengrui Company Information Table 127. Hengrui Business Overview Table 128. Hengrui Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 129. Hengrui Anticholinergic Agent Product Portfolio Table 130. Hengrui Recent Development Table 131. Pfizer Company Information Table 132. Pfizer Business Overview Table 133. Pfizer Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 134. Pfizer Anticholinergic Agent Product Portfolio Table 135. Pfizer Recent Development Table 136. Joincare Pharmaceutical Company Information Table 137. Joincare Pharmaceutical Business Overview Table 138. Joincare Pharmaceutical Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 139. Joincare Pharmaceutical Anticholinergic Agent Product Portfolio Table 140. Joincare Pharmaceutical Recent Development Table 141. Mylan Company Information Table 142. Mylan Business Overview Table 143. Mylan Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 144. Mylan Anticholinergic Agent Product Portfolio Table 145. Mylan Recent Development Table 146. Sanofi Company Information Table 147. Sanofi Business Overview Table 148. Sanofi Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 149. Sanofi Anticholinergic Agent Product Portfolio Table 150. Sanofi Recent Development Table 151. Sun Pharmaceutical Company Information Table 152. Sun Pharmaceutical Business Overview Table 153. Sun Pharmaceutical Anticholinergic Agent Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 154. Sun Pharmaceutical Anticholinergic Agent Product Portfolio Table 155. Sun Pharmaceutical Recent Development Table 156. North America Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 157. North America Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 158. North America Anticholinergic Agent Sales Market Share by Country (2021-2026) Table 159. North America Anticholinergic Agent Sales Forecast by Country (2027-2032) & (Kg) Table 160. North America Anticholinergic Agent Sales Market Share Forecast by Country (2027-2032) Table 161. North America Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Anticholinergic Agent Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Anticholinergic Agent Market Share by Country (2021-2026) Table 164. North America Anticholinergic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Anticholinergic Agent Market Share Forecast by Country (2027-2032) Table 166. Europe Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 167. Europe Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 168. Europe Anticholinergic Agent Sales Market Share by Country (2021-2026) Table 169. Europe Anticholinergic Agent Sales Forecast by Country (2027-2032) & (Kg) Table 170. Europe Anticholinergic Agent Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Anticholinergic Agent Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Anticholinergic Agent Market Share by Country (2021-2026) Table 174. Europe Anticholinergic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Anticholinergic Agent Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 178. Asia-Pacific Anticholinergic Agent Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Anticholinergic Agent Sales Forecast by Country (2027-2032) & (Kg) Table 180. Asia-Pacific Anticholinergic Agent Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Anticholinergic Agent Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Anticholinergic Agent Market Share by Country (2021-2026) Table 184. Asia-Pacific Anticholinergic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Anticholinergic Agent Market Share Forecast by Country (2027-2032) Table 186. Latin America Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 187. Latin America Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 188. Latin America Anticholinergic Agent Sales Market Share by Country (2021-2026) Table 189. Latin America Anticholinergic Agent Sales Forecast by Country (2027-2032) & (Kg) Table 190. Latin America Anticholinergic Agent Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Anticholinergic Agent Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Anticholinergic Agent Market Share by Country (2021-2026) Table 194. Latin America Anticholinergic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Anticholinergic Agent Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Anticholinergic Agent Sales by Country (2021-2026) & (Kg) Table 198. Middle East and Africa Anticholinergic Agent Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Anticholinergic Agent Sales Forecast by Country (2027-2032) & (Kg) Table 200. Middle East and Africa Anticholinergic Agent Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Anticholinergic Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Anticholinergic Agent Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Anticholinergic Agent Market Share by Country (2021-2026) Table 204. Middle East and Africa Anticholinergic Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Anticholinergic Agent Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Anticholinergic Agent Distributors List Table 209. Anticholinergic Agent Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Anticholinergic Agent Image Figure 2. Global Anticholinergic Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anticholinergic Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Anticholinergic Agent Sales (2021-2032) & (Kg) Figure 5. Muscarinic Antagonists Image Figure 6. Global Muscarinic Antagonists Sales YoY Growth (2021-2032) & (Kg) Figure 7. Nicotinic Antagonists Image Figure 8. Global Nicotinic Antagonists Sales YoY Growth (2021-2032) & (Kg) Figure 9. Global Anticholinergic Agent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Anticholinergic Agent Market Share by Type 2025 VS 2032 Figure 11. North America Anticholinergic Agent Sales Market Share in Volume by Type in 2025 Figure 12. North America Anticholinergic Agent Sales Market Share in Value by Type in 2025 Figure 13. Europe Anticholinergic Agent Sales Market Share in Volume by Type in 2025 Figure 14. Europe Anticholinergic Agent Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Anticholinergic Agent Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Anticholinergic Agent Sales Market Share in Value by Type in 2025 Figure 17. Latin America Anticholinergic Agent Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Anticholinergic Agent Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Anticholinergic Agent Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Anticholinergic Agent Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Anticholinergic Agent Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Chronic Obstructive Pulmonary Disease Image Figure 24. Global Chronic Obstructive Pulmonary Disease Sales YoY Growth (2021-2032) & (Kg) Figure 25. Parkinson's Disease Image Figure 26. Global Parkinson's Disease Sales YoY Growth (2021-2032) & (Kg) Figure 27. Surgery Image Figure 28. Global Surgery Sales YoY Growth (2021-2032) & (Kg) Figure 29. Asthma Image Figure 30. Global Asthma Sales YoY Growth (2021-2032) & (Kg) Figure 31. Global Anticholinergic Agent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Anticholinergic Agent Market Share by Application 2025 VS 2032 Figure 33. North America Anticholinergic Agent Sales Market Share in Volume by Application in 2025 Figure 34. North America Anticholinergic Agent Sales Market Share in Value by Application in 2025 Figure 35. Europe Anticholinergic Agent Sales Market Share in Volume by Application in 2025 Figure 36. Europe Anticholinergic Agent Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Anticholinergic Agent Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Anticholinergic Agent Sales Market Share in Value by Application in 2025 Figure 39. Latin America Anticholinergic Agent Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Anticholinergic Agent Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Anticholinergic Agent Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Anticholinergic Agent Sales Market Share in Value by Application in 2025 Figure 43. North America Anticholinergic Agent Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 44. North America Anticholinergic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Anticholinergic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Anticholinergic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Anticholinergic Agent Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 48. Europe Anticholinergic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Anticholinergic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Anticholinergic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Anticholinergic Agent Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 52. Asia-Pacific Anticholinergic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Anticholinergic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Anticholinergic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Anticholinergic Agent Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 56. Latin America Anticholinergic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Anticholinergic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Anticholinergic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Anticholinergic Agent Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 60. Middle East and Africa Anticholinergic Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Anticholinergic Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Anticholinergic Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Anticholinergic Agent Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Anticholinergic Agent Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Muscarinic Antagonists
  • Nicotinic Antagonists
Applications
  • Chronic Obstructive Pulmonary Disease
  • Parkinson's Disease
  • Surgery
  • Asthma
Companies covered
  • Astellas Pharma Inc
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Macleods Pharmaceuticals
  • Novartis AG
  • Perrigo
  • Teva Pharmaceutical
  • AstraZeneca
  • AbbVie
  • Hansoh Pharmaceutical
  • Hengrui
  • Pfizer
  • Joincare Pharmaceutical
  • Mylan
  • Sanofi
  • Sun Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anticholinergic Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anticholinergic Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anticholinergic Agent Market by Type
  6. 1.3.1 Muscarinic Antagonists
  7. 1.3.2 Nicotinic Antagonists
  8. 1.4 Global Anticholinergic Agent Market Size by Type
  9. 1.4.1 Global Anticholinergic Agent Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Anticholinergic Agent Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Anticholinergic Agent Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Anticholinergic Agent Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Anticholinergic Agent Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Anticholinergic Agent Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Anticholinergic Agent Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Anticholinergic Agent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anticholinergic Agent Industry Trends
  2. 2.2 Anticholinergic Agent Industry Drivers
  3. 2.3 Anticholinergic Agent Industry Opportunities and Challenges
  4. 2.4 Anticholinergic Agent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anticholinergic Agent Revenue (2021-2026)
  2. 3.2 Global Top Players by Anticholinergic Agent Sales (2021-2026)
  3. 3.3 Global Top Players by Anticholinergic Agent Price (2021-2026)
  4. 3.4 Global Anticholinergic Agent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anticholinergic Agent Major Company Production Sites & Headquarters
  6. 3.6 Global Anticholinergic Agent Company, Product Type & Application
  7. 3.7 Global Anticholinergic Agent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anticholinergic Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anticholinergic Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anticholinergic Agent Tier 1, Tier 2, and Tier 3
4 Anticholinergic Agent Regional Status and Outlook
  1. 4.1 Global Anticholinergic Agent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anticholinergic Agent Historic Market Size by Region
  3. 4.2.1 Global Anticholinergic Agent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anticholinergic Agent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anticholinergic Agent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anticholinergic Agent Forecasted Market Size by Region
  7. 4.3.1 Global Anticholinergic Agent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anticholinergic Agent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anticholinergic Agent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anticholinergic Agent by Application
  1. 5.1 Anticholinergic Agent Market by Application
  2. 5.1.1 Chronic Obstructive Pulmonary Disease
  3. 5.1.2 Parkinson's Disease
  4. 5.1.3 Surgery
  5. 5.1.4 Asthma
  6. 5.2 Global Anticholinergic Agent Market Size by Application
  7. 5.2.1 Global Anticholinergic Agent Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anticholinergic Agent Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anticholinergic Agent Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anticholinergic Agent Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anticholinergic Agent Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anticholinergic Agent Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anticholinergic Agent Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anticholinergic Agent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Astellas Pharma Inc
  2. 6.1.1 Astellas Pharma Inc Company Information
  3. 6.1.2 Astellas Pharma Inc Business Overview
  4. 6.1.3 Astellas Pharma Inc Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Astellas Pharma Inc Anticholinergic Agent Product Portfolio
  6. 6.1.5 Astellas Pharma Inc Recent Developments
  7. 6.2 Aurobindo Pharma
  8. 6.2.1 Aurobindo Pharma Company Information
  9. 6.2.2 Aurobindo Pharma Business Overview
  10. 6.2.3 Aurobindo Pharma Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aurobindo Pharma Anticholinergic Agent Product Portfolio
  12. 6.2.5 Aurobindo Pharma Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Anticholinergic Agent Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Anticholinergic Agent Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Macleods Pharmaceuticals
  26. 6.5.1 Macleods Pharmaceuticals Company Information
  27. 6.5.2 Macleods Pharmaceuticals Business Overview
  28. 6.5.3 Macleods Pharmaceuticals Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Macleods Pharmaceuticals Anticholinergic Agent Product Portfolio
  30. 6.5.5 Macleods Pharmaceuticals Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis AG Anticholinergic Agent Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Perrigo
  38. 6.7.1 Perrigo Company Information
  39. 6.7.2 Perrigo Business Overview
  40. 6.7.3 Perrigo Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Perrigo Anticholinergic Agent Product Portfolio
  42. 6.7.5 Perrigo Recent Developments
  43. 6.8 Teva Pharmaceutical
  44. 6.8.1 Teva Pharmaceutical Company Information
  45. 6.8.2 Teva Pharmaceutical Business Overview
  46. 6.8.3 Teva Pharmaceutical Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceutical Anticholinergic Agent Product Portfolio
  48. 6.8.5 Teva Pharmaceutical Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Anticholinergic Agent Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Anticholinergic Agent Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
  61. 6.11 Hansoh Pharmaceutical
  62. 6.11.1 Hansoh Pharmaceutical Company Information
  63. 6.11.2 Hansoh Pharmaceutical Business Overview
  64. 6.11.3 Hansoh Pharmaceutical Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hansoh Pharmaceutical Anticholinergic Agent Product Portfolio
  66. 6.11.5 Hansoh Pharmaceutical Recent Developments
  67. 6.12 Hengrui
  68. 6.12.1 Hengrui Company Information
  69. 6.12.2 Hengrui Business Overview
  70. 6.12.3 Hengrui Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hengrui Anticholinergic Agent Product Portfolio
  72. 6.12.5 Hengrui Recent Developments
  73. 6.13 Pfizer
  74. 6.13.1 Pfizer Company Information
  75. 6.13.2 Pfizer Business Overview
  76. 6.13.3 Pfizer Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Pfizer Anticholinergic Agent Product Portfolio
  78. 6.13.5 Pfizer Recent Developments
  79. 6.14 Joincare Pharmaceutical
  80. 6.14.1 Joincare Pharmaceutical Company Information
  81. 6.14.2 Joincare Pharmaceutical Business Overview
  82. 6.14.3 Joincare Pharmaceutical Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Joincare Pharmaceutical Anticholinergic Agent Product Portfolio
  84. 6.14.5 Joincare Pharmaceutical Recent Developments
  85. 6.15 Mylan
  86. 6.15.1 Mylan Company Information
  87. 6.15.2 Mylan Business Overview
  88. 6.15.3 Mylan Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Mylan Anticholinergic Agent Product Portfolio
  90. 6.15.5 Mylan Recent Developments
  91. 6.16 Sanofi
  92. 6.16.1 Sanofi Company Information
  93. 6.16.2 Sanofi Business Overview
  94. 6.16.3 Sanofi Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Sanofi Anticholinergic Agent Product Portfolio
  96. 6.16.5 Sanofi Recent Developments
  97. 6.17 Sun Pharmaceutical
  98. 6.17.1 Sun Pharmaceutical Company Information
  99. 6.17.2 Sun Pharmaceutical Business Overview
  100. 6.17.3 Sun Pharmaceutical Anticholinergic Agent Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sun Pharmaceutical Anticholinergic Agent Product Portfolio
  102. 6.17.5 Sun Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Anticholinergic Agent Sales by Country
  2. 7.1.1 North America Anticholinergic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anticholinergic Agent Sales by Country (2021-2026)
  4. 7.1.3 North America Anticholinergic Agent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anticholinergic Agent Market Size by Country
  6. 7.2.1 North America Anticholinergic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anticholinergic Agent Market Size by Country (2021-2026)
  8. 7.2.3 North America Anticholinergic Agent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anticholinergic Agent Sales by Country
  2. 8.1.1 Europe Anticholinergic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anticholinergic Agent Sales by Country (2021-2026)
  4. 8.1.3 Europe Anticholinergic Agent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anticholinergic Agent Market Size by Country
  6. 8.2.1 Europe Anticholinergic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anticholinergic Agent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anticholinergic Agent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anticholinergic Agent Sales by Country
  2. 9.1.1 Asia-Pacific Anticholinergic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anticholinergic Agent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anticholinergic Agent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anticholinergic Agent Market Size by Country
  6. 9.2.1 Asia-Pacific Anticholinergic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anticholinergic Agent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anticholinergic Agent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anticholinergic Agent Sales by Country
  2. 10.1.1 South America Anticholinergic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anticholinergic Agent Sales by Country (2021-2026)
  4. 10.1.3 South America Anticholinergic Agent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anticholinergic Agent Market Size by Country
  6. 10.2.1 South America Anticholinergic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anticholinergic Agent Market Size by Country (2021-2026)
  8. 10.2.3 South America Anticholinergic Agent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anticholinergic Agent Sales by Country
  2. 11.1.1 Middle East and Africa Anticholinergic Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anticholinergic Agent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anticholinergic Agent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anticholinergic Agent Market Size by Country
  6. 11.2.1 Middle East and Africa Anticholinergic Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anticholinergic Agent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anticholinergic Agent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anticholinergic Agent Value Chain Analysis
  2. 12.1.1 Anticholinergic Agent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anticholinergic Agent Production Mode & Process
  7. 12.2 Anticholinergic Agent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anticholinergic Agent Distributors
  10. 12.2.3 Anticholinergic Agent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst